Last update 12 Dec 2024
LVGN-3616
Last update 12 Dec 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms Anti-PD1 antibody - Lyvgen Biopharma, LVGN 3616, LVGN-3616 |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with LVGN-3616Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
100 Clinical Results associated with LVGN-3616
Login to view more data
100 Translational Medicine associated with LVGN-3616
Login to view more data
100 Patents (Medical) associated with LVGN-3616
Login to view more data
100 Deals associated with LVGN-3616
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Head and neck cancer metastatic | Phase 1 | US | 12 Nov 2021 | |
| Human Papillomavirus-Related Solid Tumors | Phase 1 | US | 12 Nov 2021 | |
| Metastatic Esophageal Carcinoma | Phase 1 | US | 12 Nov 2021 | |
| Metastatic hepatocellular carcinoma | Phase 1 | US | 12 Nov 2021 | |
| Metastatic Soft Tissue Sarcoma | Phase 1 | US | 12 Nov 2021 | |
| Metastatic Solid Tumor | Phase 1 | US | 12 Nov 2021 | |
| Ovarian Cancer | Phase 1 | US | 12 Nov 2021 | |
| Stomach Cancer | Phase 1 | US | 12 Nov 2021 | |
| Uveal Melanoma | Phase 1 | US | 12 Nov 2021 | |
| Neoplasms | Phase 1 | CN | 22 Jan 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free